[1] Inzerillo A, Meloni MF, Taibbi A, et al. Loco-regional treatment of hepatocellular carcinoma: role of contrast-enhanced ultrasonography[J]. World J Hepatol, 2022, 14(5):911-922. DOI:10.4254/wjh.v14.i5.911.
[2] Oh S, Kwon H, Lim K, et al. The feasibility of early response evaluation using superb microvascular imaging one day after transcatheter arterial chemoembolization for hepatocellular carcinoma[J]. J Clin Ultrasound, 2023, 51(5): 866-875. DOI:10.1002/jcu.23449.
[3] Ding W, Meng Y, Ma J, et al. Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions[J]. J Hepatol, 2025, 83(2):426-439. DOI: 10.1016/j.jhep.2025.01.011.
[4] Li W, Liu Z, Cheng M, et al. Deep learning model integrating contrast-enhanced ultrasound spatiotemporal imaging with clinical data for the differential diagnosis between hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Radiol Med, 2026, 131(2):302-310. DOI: 10.1007/s11547-025-02132-6.
[5] Li Y, Yu XL, Jing X, et al. Non-invasive Kupffer-CEUS enhances the accuracy of focal liver lesions diagnosis in patients with liver cirrhosis or fibrosis: a prospective multicenter study from China[J]. Liver Cancer, 2025, 14(4):435-445. DOI: 10.1159/000543501.
[6] Zhang P, Zhou Q, Zeng Z. The impact of ultrasound contrast-enhanced fusion virtual navigation technology-guided microwave ablation and standard microwave ablation on the local tumor progression of hepatocellular carcinoma with unclear ultrasound images[J]. Eur J Med Res, 2025, 30(1):451. DOI: 10.1186/s40001-025-02608-1.
[7] Ding W, Wu J, Dou J, et al. Biologically explicable multimodal model predicting local tumor progression and tumor invasive‐ness of hepatocellular carcinoma[J/OL]. Hepatology, 2026,[2026-03-12]. DOI: 10.1097/HEP. 0000000000001678. [pub‐lished online ahead of print].
[8] Aziz MU, Eisenbrey JR, Deganello A, et al. Microvascular flow imaging: a state-of-the-art review of clinical use and promise[J]. Radiology, 2022, 305(2): 250-264. DOI: 10.1148/radiol.213303.
[9] Rhee H, Park YN, Choi JY. Advances in understanding hepatocellular carcinoma vasculature: implications for diagnosis,prognostication, and treatment[J]. Korean J Radiol, 2024, 25(10):887-901. DOI: 10.3348/kjr.2024.0307.
[10] Bartolotta TV, Taibbi A, Randazzo A, et al. New frontiers in liver ultrasound:from mono to multi parametricity[J]. World J Gastrointest Oncol, 2021, 13(10):1302-1316. DOI: 10.4251/wjgo.v13.i10.1302.
[11] Huang C, Song P, Trzasko JD, et al. Simultaneous noise suppression and incoherent artifact reduction in ultrafast ultrasound vascular imaging[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2021, 68(6):2075-2085. DOI: 10.1109/TUFFC.2021.3055498.
[12] Rónaszéki AD, Dudás I, Zsély B, et al. Microvascular flow imaging to differentiate focal hepatic lesions:the spoke-wheel pattern as a specific sign of focal nodular hyperplasia[J].Ultrasonography, 2022, 42(1):172-181. DOI: 10.14366/usg.22028.
[13] Aslan HS, Arslan M, Alver KH, et al. Role of superb microvascular imaging vascularity index values and vascularity patterns in the differential diagnosis of malignant liver lesions[J]. Abdom Radiol (NY), 2024, 50(6):2426-2439.DOI: 10.1007/s00261-024-04711-z.
[14] Ota Y, Aso K, Yokoo H, et al. Noninvasive visualization of tumor blood vessels within hepatocellular carcinoma by application of superb microvascular imaging to contrast-enhanced ultrasonography[J]. Diagnostics (Basel), 2024, 14(7): 678. DOI:10.3390/diagnostics14070678.
[15] Couture O, Hingot V, Heiles B, et al. Ultrasound localization microscopy and super-resolution: a state of the art[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2018, 65(8):
1304-1320. DOI: 10.1109/TUFFC.2018.2850811.
[16] Harput S, Christensen-Jeffries K, Ramalli A, et al. 3-D super-resolution ultrasound imaging with a 2-D sparse array[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2019,67(2):269-277. DOI: 10.1109/TUFFC.2019.2943646.
[17] Zeng QQ, An SZ, Chen CN, et al. Focal liver lesions: multiparametric microvasculature characterization via super-resolution ultrasound imaging[J]. Eur Radiol Exp, 2024, 8(1):138. DOI: 10.1186/s41747-024-00540-3.
[18] Smith CAB, Wilson H, Yan J, et al. Quantitative image markers of super-resolution ultrasound[J]. EBioMedicine,2026, 124:106108. DOI: 10.1016/j.ebiom.2025.106108.
[19] Lowerison MR, Huang C, Lucien F, et al. Ultrasound localization microscopy of renal tumor xenografts in chicken embryo is correlated to hypoxia[J]. Sci Rep, 2020, 10(1):2478.DOI: 10.1038/s41598-020-59338-z.
[20] Gao JY, Hou C. Progresses and clinical application of super-resolution ultrasound imaging: a narrative review[J]. Ultrasound J, 2025, 17(1):29. DOI: 10.1186/s13089-025-00432-6.
[21] Zhang G, Liao C, Hu JR, et al. Nanodroplet-based super-resolution ultrasound localization microscopy[J]. ACS Sens, 2023, 8(9):3294-3306. DOI: 10.1021/acssensors.3c00418.
[22] Dong F, An J, Zhang J, et al. Blinking acoustic nanodroplets enable fast super-resolution ultrasound imaging[J]. ACS Nano, 2021, 15(10): 16913-16923. DOI: 10.1021/acsnano. 1c07896.
[23] Dong FJ, Xu JF, Du D, et al. 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions:a retrospective analysis of 83 cases[J]. Ultrasonics, 2016, 70:221-226. DOI: 10.1016/j.ultras.2016.05.007.
[24] Lu Y, Liu B, Zheng Y, et al. Application of real-time three-dimensional contrast-enhanced ultrasound using SonoVue for the evaluation of focal liver lesions: a prospective single-center study[J]. Am J Transl Res, 2018, 10(5):1469-1480.
[25] Dong Y, Koch JBH, Löwe AL, et al. VueBox for quantitative analysis of contrast-enhanced ultrasound in liver tumors[J]. Clin Hemorheol Microcirc, 2022, 80(4):473-486. DOI: 10.3233/CH-211261.
[26] Zhou BY, Liu H, Pu YY, et al. Quantitative analysis of pre-treatment dynamic contrast-enhanced ultrasound for assessing the response of colorectal liver metastases to chemotherapy plus targeted therapy: a dual-institutional study[J]. Abdom Radiol (NY), 2024, 49(2):414-424. DOI:10.1007/s00261-023-04055-0.
[27] Lu XY, Jiang J, Chen S, et al. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma[J]. Eur J Radiol, 2024, 175:111439. DOI: 10.1016/j.ejrad.2024.111439.
[28] Dietrich CF, Nolsøe CP, Barr RG, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound in the liver: update 2020-WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS[J]. Ultraschall Med, 2020, 41(5):562-585. DOI: 10.1055/a-1177-0530.
[29] Lee JY, Minami Y, Choi BI, et al. The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using Sonazoid[J]. J Med Ultrasound, 2020, 28(2):59-82. DOI: 10.4103/jmu.Jmu_124_19.
[30] Jeong WK, Kang HJ, Choi SH, et al. Diagnosing hepatocellular carcinoma using Sonazoid contrast-enhanced ultrasonography: 2023 guidelines from the Korean Society of Radiology and the Korean Society of Abdominal Radiology[J]. Korean J Radiol, 2023, 24(6): 482-497. DOI: 10.3348/kjr.2023.0324.
[31] Baron Toaldo M, Salvatore V, Marinelli S, et al. Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma[J]. Mol Imaging Biol, 2015, 17(1):29-37. DOI: 10.1007/s11307-014-0764-x.
[32] Sugimoto K, Moriyasu F, Negishi Y, et al. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft[J]. J Ultrasound Med, 2012, 31(12):1909-1916.DOI: 10.7863/jum.2012.31.12.1909.
[33] Xiong X, Zhou H, Xu X, et al. Ultrasound molecular imaging enhances high-intensity focused ultrasound ablation on liver cancer with B7-H3-targeted microbubbles[J]. Cancer Med,2024, 13(20):e70341. DOI: 10.1002/cam4.70341.
[34] Qiu YJ, Cao JY, Liao JH, et al. CXCR4-targeted ultrasound microbubbles for imaging and enhanced chemotherapy/immunotherapy in liver cancer[J]. Acta Biomater, 2025, 197:416-430. DOI: 10.1016/j.actbio.2025.03.018.
[35] Zhang J, Luo X, Yang X, et al. Ultrasound-responsive nanodelivery system of GPC3-targeting and sonosensitizer for visualized hepatocellular carcinoma therapy[J]. Int J Nanomedicine, 2024, 19:7015-7031. DOI: 10.2147/IJN.S470847.
[36] 王婷婷,任新平 . 剪切波频散成像在肝脏疾病诊断中的应用进展 [J]. 临床 超 声 医 学 杂 志 , 2025, 27(2): 170-173. DOI:10.3969/j.issn.1008-6978.2025.02.016.
[37] Rouze NC, Deng Y, Trutna CA, et al. Characterization of viscoelastic materials using group shear wave speeds[J]. IEEE Trans Ultrason Ferroelectr Freq Control, 2018, 65(5):780-794.DOI: 10.1109/TUFFC.2018.2815505.
[38] Wang K, Yu D, Li G, et al. Comparison of the diagnostic performance of shear wave elastography with shear wave dispersion for pre-operative staging of hepatic fibrosis in
patients with hepatocellular carcinoma[J]. Eur J Radiol, 2022,154:110459. DOI: 10.1016/j.ejrad.2022.110459.
[39] Qiu T, Zhou R, Li J, et al. Ultrasound shear wave viscoelastic imaging combined with shear wave elastography for characterization of focal liver lesions[J]. J Biomech, 2025,194:113073. DOI: 10.1016/j.jbiomech.2025.113073.
[40] Ferraioli G, Barr RG, Berzigotti A, et al. WFUMB guideline/guidance on liver multiparametric ultrasound: part 1. Update to 2018 guidelines on liver ultrasound elastography[J]. Ultrasound Med Biol, 2024, 50(8):1071-1087. DOI: 10.1016/j.ultrasmedbio.2024.03.013.
[41] Zhang LX, Dioguardi Burgio M, Vilgrain V, et al. Quantitative ultrasound and ultrasound-based elastography for chronic liver disease: practical guidance, from the AJR special series on quantitative imaging[J]. AJR Am J Roentgenol, 2024, 225(1):e2431709. DOI: 10.2214/AJR.24.31709.
[42] Gupta I, Fenkel JM, Eisenbrey JR, et al. A noninvasive ultrasound based technique to identify treatment responders in patients with portal hypertension[J]. Acad Radiol, 2021, 28 Suppl 1:S128-S137. DOI: 10.1016/j.acra.2020.11.023.
[43] Imajo K, Toyoda H, Yasuda S, et al. Utility of ultrasound-guided attenuation parameter for grading steatosis with reference to MRI-PDFF in a large cohort[J]. Clin Gastroenterol Hepatol,2022, 20(11):2533-2541.e7. DOI: 10.1016/j.cgh.2021.11.003.
[44] Kubale R, Schneider G, Lessenich CPN, et al. Ultrasound-derived fat fraction for hepatic steatosis assessment: prospective study of agreement with MRI PDFF and sources of variability in a heterogeneous population[J]. AJR Am J Roentgenol,2024, 222(6):e2330775. DOI: 10.2214/AJR.23.30775.
[45] Dioguardi Burgio M, Castera L, Oufighou M, et al.Prospective comparison of attenuation imaging and controlled attenuation parameter for liver steatosis diagnosis in patients with nonalcoholic fatty liver disease and type 2 diabetes[J].Clin Gastroenterol Hepatol, 2024, 22(5):1005-1013.e27. DOI:10.1016/j.cgh.2023.11.034.
[46] Li XQ, Cheng GW, Akiyama I, et al. Attenuation imaging:diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients[J]. World J Gastroenterol, 2025, 31(11):102795. DOI:10.3748/wjg.v31.i11.102795.
[47] Liu F, Bi M, Jing X, et al. Multiparametric US for identifying metabolic dysfunction-associated steatohepatitis:a prospective multicenter study[J]. Radiology, 2024, 310(3): e232416. DOI:10.1148/radiol.232416.
[48] Yu X, Song Z, Chang X, et al. Artificial intelligence in ultrasound diagnosis of liver nodules:a comprehensive review of B-mode and contrast-enhanced applications[J]. Adv
Ultrasound Diagn Ther, 2025, 9(4): 326-346. DOI: 10.26599/AUDT.2025.250098.
[49] Chen J, Zhang W, Bao J, et al. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Abdom Radiol (NY),2023, 49(1):93-102. DOI: 10.1007/s00261-023-04089-4.
[50] Qin X, Hu X, Xiao W, et al. Preoperative evaluation of hepatocellular carcinoma differentiation using contrast-enhanced ultrasound-based deep-learning radiomics model[J]. J Hepatocell Carcinoma, 2023, 10:157-168. DOI: 10.2147/JHC.S400166.
[51] Lu D, Qin C, Wang LF, et al. B-mode ultrasound and contrast-enhanced ultrasound-based radiomics interpretable analysis for the prediction of macrotrabecular-massive subtype of hepatocellular carcinoma[J]. Ultrasound J, 2025,17(1):53. DOI: 10.1186/s13089-025-00452-2.
[52] Dong Y, Zuo D, Qiu YJ, et al. Preoperative prediction of microvascular invasion in hepatocellular carcinoma based on Kupffer phase radiomics features of Sonazoid contrast-enhanced ultrasound: a prospective study[J]. Clin Hemorheol Microcirc,2022, 81(1):97-107. DOI: 10.3233/CH-211363.
[53] Liu D, Yang K, Zhang C, et al. Deep learning with contrast-enhanced ultrasound for preoperative prediction of early recurrence in hepatocellular carcinoma after hepatectomy[J]. J Multidiscip Healthc, 2025, 18:6829-6841. DOI: 10.2147/JMDH.S555110.
[54] 中华医学会超声医学分会, 中国研究型医院学会肿瘤介入专业委员会 . 影像引导原发性肝癌消融指南(2023 版)[J]. 中华肝脏病杂志 , 2024, 32(2): 97-112. DOI: 10.3760/cma.j.cn501113-20240108-00017.
[55] 中华人民共和国国家卫生健康委员会医政司 . 原发性肝癌诊疗指南 (2026 年版)[J]. 中华消化外科杂志, 2026, 25(4):423-482.DOI:10.3760/cma.j.cn115610-20260409-00187.
[56] Saeed SU, Ramalhinho J, Montaña-Brown N, et al. Guided ultrasound acquisition for nonrigid image registration using reinforcement learning[J]. Med Image Anal, 2025, 102:103555. DOI: 10.1016/j.media.2025.103555.
[57] Uppal V, Sondekoppam RV, Ganapathy S. Effect of beam steering on the visibility of echogenic and non-echogenic needles: a laboratory study[J]. Can J Anaesth, 2014, 61(10):909-915. DOI: 10.1007/s12630-014-0207-9.
[58] Hovgesen CH, Wilhjelm JE, Vilmann P, et al. Echogenic surface enhancements for improving needle visualization in ultrasound: a PRISMA systematic review[J]. J Ultrasound Med, 2021, 41(2):311-325. DOI: 10.1002/jum.15713.
[59] Yan W, Ding Q, Chen J, et al. Learning-based needle tip tracking in 2D ultrasound by fusing visual tracking and motion prediction[J]. Med Image Anal, 2023, 88: 102847.DOI: 10.1016/j.media.2023.102847.
[60] Che H, Qin J, Chen Y, et al. Improving needle tip tracking and detection in ultrasound-based navigation system using deep learning-enabled approach[J]. IEEE J Biomed Health Inform,2024, 28(5):2930-2942. DOI: 10.1109/JBHI.2024.3353343.
[61] Papadopoulou M, Chlorogiannis DD, Moschovaki-Zeiger O,et al. Electromagnetic navigation system with a marker option for computed tomography-guided microwave ablation of undetectable or inconspicuous hepatic tumors in non-enhanced scans: a feasibility study[J]. Cancers (Basel), 2025, 18(1): 25.DOI: 10.3390/cancers18010025.
[62] Ringe KI, Pöhler GH, Rabeh H, et al. Electromagnetic navigation system-guided microwave ablation of hepatic tumors:a matched cohort study[J]. Cardiovasc Intervent Radiol, 2021,44(3):500-506. DOI: 10.1007/s00270-020-02761-6.
[63] Uribe Rivera AK, Seeliger B, Goffin L, et al. Robotic assistance in percutaneous liver ablation therapies:a systematic review and meta-analysis[J]. Ann Surg Open, 2024, 5(2):e406. DOI: 10.1097/AS9.0000000000000406.
[64] Sigdel M, Fang Y, Sun Z, et al. Robotic navigation-assisted percutaneous liver puncture:a pilot study[J]. Quant Imaging Med Surg, 2025, 15(2):1543-1554. DOI: 10.21037/qims-24-1584.
[65] Li F, Bi Y, Huang D, et al. Robotic CBCT meets robotic ultrasound[J]. Int J Comput Assist Radiol Surg, 2025, 20(6):1049-1057. DOI: 10.1007/s11548-025-03336-x.
[66] Zhang B, Chen K, Yao Y, et al. Semi-automatic puncture robotic system based on real-time multi-modal image fusion:preclinical evaluation[J]. Int J Comput Assist Radiol Surg,2025, 20(12):2479-2489. DOI: 10.1007/s11548-025-03471-5.
[67] Nakayama M, Zhang B, Kuromatsu R, et al. Real-time 3D US-CT fusion-based semi-automatic puncture robot system:clinical evaluation[J]. Int J Comput Assist Radiol Surg, 2025,20(9):1817-1827. DOI: 10.1007/s11548-025-03489-9.
[68] Zhang K, Ru J, Wang W, et al. Vision transformer-based model can optimize curative-intent treatment for patients with recurrent hepatocellular carcinoma[J]. Nat Commun, 2025,16(1):4081. DOI: 10.1038/s41467-025-59197-0.
[69] Servin F, Collins JA, Heiselman JS, et al. Simulation of image-guided microwave ablation therapy using a digital twin computational model[J]. IEEE Open J Eng Med Biol, 2023, 5:107-124. DOI: 10.1109/OJEMB.2023.3345733.
[70] Tao F, Qi Q. Make more digital twins[J]. Nature, 2019,573(7775):490-491. DOI: 10.1038/d41586-019-02849-1.
[71] Tao F, Zhang H, Zhang C. Advancements and challenges of digital twins in industry[J]. Nat Comput Sci, 2024, 4(3):169-177. DOI: 10.1038/s43588-024-00603-w.
[72] Evans M, Kang S, Bajaber A, et al. Augmented reality for surgical navigation: a review of advanced needle guidance systems for percutaneous tumor ablation[J]. Radiol Imaging Cancer, 2025, 7(1):e230154. DOI: 10.1148/rycan.230154.
[73] Spinczyk D, Rosiak G, Żyłkowski J, et al. Initial evaluation of a mixed-reality system for image-guided navigation during percutaneous liver tumor ablation[J]. Comput Med Imaging Graph, 2026, 128:102714. DOI: 10.1016/j.compmedimag.2026.102714.
[74] Salazar Carrasco L, Sánchez-Varo I, Caballero Jorna D, et al. System for assistance in ultrasound-guided percutaneous hepatic interventions using augmented reality: first steps[J].Healthc Technol Lett, 2025, 12(1):e12110. DOI: 10.1049/htl2.12110.